« February 2012 »
February
MoTuWeThFrSaSu
12345
6789101112
13141516171819
20212223242526
272829
Newsletter

Your mail address

HTML
Text
Visit our archives
 

News & Events

News

News Item Get insight into the next EU Framework Programme
The European Commission elaborated a proposal for the next Framework Programme for Research and Innovation named Horizon 2020. Get key data, the main objectives and overview of the structure in the following presentation.
News Item New market research report on Nanotechnology in Medical Applications
The global nanomedicine market reached $63.8 billion in 2010 and $72.8 billion in 2011. The market is expected to grow to $130.9 billion by 2016 at a compound annual growth rate (CAGR) of 12.5% between years 2011 and 2016.
News Item Call for Papers and Posters for the European Summit for Clinical Nanomedicine 2012
The call for Papers for the upcoming European Summit for Clinical Nanomedicine is open till 11th February 2012!
News Item NANOFAR: New European Doctorate in Nanomedicine and Pharmaceutical Innovation
NANOFAR is a three-year PhD thesis in nanomedicine and pharmaceutical innovation, co-supervised by partners in two different countries and including a one-year mobility period.
News Item Catalan Strategic Agenda of Nanobiotechnology published
The IBEC-coordinated Connect-EU Nanobio + Nanomed Working Group has published a 'roadmap' for nanobiotechnology capabilities in Catalonia.
News Item Breaking down barriers to research – consultation on the European Research Area
The European Commission, DG Research and Innovation, launched on 13th September a public consultation on Breaking down barriers to research.
News Item Nanobiotix Starts Clinical Trial with Lead Product NBTXR3
Paris, France - September 13th 2011 - Nanobiotix, a company developing novel cancer nanotherapeutics, announced today that its lead compound NBTXR3 has received the formal authorization from the French Medicine Agency, AFSSAPS, to start the first clinical trial.
News Item ETPN White Paper on "Improving Translation of Public Healthcare Nano-Research in Europe"
In this paper the ETP Nanomedicine together with the Nanomedicine community at large elaborates on the difficulties of translating research results in Nanomedicine from bench to bedside and from lab to products and provides four recommendations for actions to improve Nanomedicine research & development in Europe.
News Item New article published: How do we develop nanopharmaceuticals under open innovation?
Following article from Mike Eaton has been published in the nanomedicine journal.
News Item EUMINAfab 5th Call for Proposals
EUMINAfab: European Research Infrastructure for multimaterial micro and nano fabrication and characterization opens the 5th call for no fee access to 37 installations containing equipment to high end micro and nano technologies.
News Item FDA approves Adcetris to treat two types of lymphoma
The U.S. Food and Drug Administration approved on 19th August Adcetris (brentuximab vedotin) to treat Hodgkin lymphoma (HL) and a rare lymphoma known as systemic anaplastic large cell lymphoma (ALCL). (Source: FDA)
News Item Launch of the BioNanoMed Catalunya Platform
The first platform that connects Catalan groups, university, hospitals and corporate research in nanotechnology applied to health and biotechnology.
News Item European Perspectives in Personalised Medicine
The conference "European Perspectives in Personalised Medicine" took place on 12 -13 May 2011 in Brussels and gave substantial elements towards personalised medicine in Europe.
News Item New wind on the ETPN Working Group dedicated to Regenerative Medicine
A new Chair as well as a new Vice-Chair has been elected to lead the RegMed WG
News Item Flash Presentations Session on CLINAM 2011
The European Technology Platform on Nanomedicine (ETPN) is organising a Flash Presentations Session on the CLINAM 2011 Conference dedicated to research institutes, academia, large and small companies to present their activities and project ideas during short talks.
News Item Info Consultation on future EU Research and Innovation Funding
Consultation: Green Paper on a Common Strategic Framework for future EU Research and Innovation Funding
News Item THE EUROPEAN JOINT CONFERENCE FOR NANOMEDICINE (CLINAM 2011)
4th European conference for clinical nanomedicine 2011 (CLINAM 2011) in collaboration with the European Technology Platform on Nanomedicine (ETPN), the European Medicines Agency (EMA) and the European Science Foundation (ESF).
News Item Pfizer plans to close an R&D facility in the UK
Article from www.pharmalot.com (1st Februar 2011). As part of its ongoing effort to brace for the loss of the Lipitor patent, Pfizer now plans to close an R&D facility in Sandwick, Kent in the UK, which employs 2,400 jobs and was where Viagra was born.
News Item MOLECULAR ENGINEERING SUMMER SCHOOL
Summerschool Biophysics of lipids and lipid-protein interactions: from biomembranes to molecular engineering, drug delivery and imaging, takes place in Utö Island, Finland, 4-11 June 2011.
News Item THE 3rd EURONANOMED JOINT TRANSNATIONAL CALL FOR PROPOSALS IS OPEN
It is strongly advised that all applicants contact their EuroNanoMed National Contact Point in good time before the submission of a proposal.
News Item Nanobiotix and the ETPN launch the first Nanomedicine TV
PARIS & BERLIN - Nanomed TV www.dailymotion.com/nanomedTV foresees to become the main hub for Nanomedicine thanks to its initiators, two major European players in nanomedicine: the European Technology Platform on Nanomedicine (ETPN) and Nanobiotix. Nanomed TV will make information accessible, aiming at answering what people need and wish to know about Nanomedicine.
News Item Cedars-Sinai 'nano-drug' hits brain-tumor target found in 2001
The system uses a unique triggering device to deliver antitumor drugs directly into brain tumors cells, unlike other drugs of its kind.
News Item ETPN Participation in the „Smart Materials for Biofunctionalized Implants and Engineered Tissue” workshop
The ETPN participated in the Workshop „Smart Materials for Biofunctionalized Implants and Engineered Tissue” organised by the REBIRTH Cluster of Excellence on 30th November 2010 in Brussels, Belgium.
News Item Innovation Union: Commission launches consultation on active & healthy ageing
The European Commission is seeking the views of public and private organisations, companies and individual citizens on how Europe could scale up innovation to meet the challenges of the ageing population in Europe, and in particular on a pilot European Innovation Partnership (EIP) on active and healthy ageing, as set out in the Innovation Union Flagship Initiative, presented on 6 October by Maire Geoghegan Quinn, European Commissioner for Research, Innovation and Science and Antonio Tajani, Vice-President for Industry and Entrepreneurship.
News Item Retrospective: ETP Nanomedicine General Assembly and Annual Forum 2010
The 2010 edition of the General Assembly and Annual Forum of the European Technology Platform on Nanomedicine took place in the Congress Centre of the Cariplo Foundation in Milan on 14th and 15th October.
More...
 
Document Actions